Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Number of holders
-
404
-
Total 13F shares, excl. options
-
519,494,143
-
Shares change
-
-35,554,501
-
Total reported value, excl. options
-
$5,059,454,033
-
Value change
-
-$346,038,930
-
Put/Call ratio
-
111%
-
Number of buys
-
149
-
Number of sells
-
170
-
Price
-
$9.74
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q3 2021
As of 30 Sep 2021 TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) had 404 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 519,494,143 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, Berkshire Hathaway Inc, BlackRock Inc., ABRAMS CAPITAL MANAGEMENT, L.P., Migdal Insurance & Financial Holdings Ltd., MENORA MIVTACHIM HOLDINGS LTD., Clal Insurance Enterprises Holdings Ltd, STATE STREET CORP, Phoenix Holdings Ltd., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This table shows 408 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.